AI biomarker improves colorectal cancer treatment decisions; routine data may also enable risk prediction
According to a report, an AI biomarker improves treatment decision-making in colorectal cancer. Separate research suggests AI can use routine health data to identify people at higher risk of common cancers.
Who is affected and how
- doctor
- Oncologists may gain a new molecular and AI-based aid for treatment decisions.
- health policy
- Risk prediction based on routine data could underpin targeted screening programmes.
Sources
- Revolutionary AI biomarker improves colorectal cancer treatment decision-makingcordis · Oct 30, 2026
- Revolutionary AI biomarker improves colorectal cancer treatment decision-making | Histotype Px Project | Results in Brief | HORIZON | CORDIS | European Commissioncordis.europa.eu · Oct 30, 2026
- AI could help identify people at higher risk of common cancers using routine health datamedicalxpress.com · Oct 26, 2026
- AI may predict the risk of common cancers using routine health dataknowridge.com · Oct 28, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.